532 related articles for article (PubMed ID: 34187307)
21. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
22. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
Front Immunol; 2022; 13():950365. PubMed ID: 36159855
[TBL] [Abstract][Full Text] [Related]
23. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
[TBL] [Abstract][Full Text] [Related]
24. Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
Li Y; Qi D; Zhu B; Ye X
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540684
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
26. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma.
Wang Z; Cheng H; Xu H; Yu X; Sui D
Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy.
Wang Y; Sun N; He R; Wang Z; Jin J; Gao T; Qu J
Clin Exp Med; 2024 May; 24(1):92. PubMed ID: 38693353
[TBL] [Abstract][Full Text] [Related]
28. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
Zhang X; Pang X; Huang Y; Qian S
Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021
[TBL] [Abstract][Full Text] [Related]
29. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
30. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y
Front Genet; 2020; 11():994. PubMed ID: 33193582
[TBL] [Abstract][Full Text] [Related]
31. A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms.
Chen X; Mo S; Zong L; Yu S; Lu Z; Chen J
Neuroendocrinology; 2022; 112(12):1187-1199. PubMed ID: 35609514
[TBL] [Abstract][Full Text] [Related]
32. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Ma J; Yang D; Ma XX
Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
[TBL] [Abstract][Full Text] [Related]
33. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
34. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
[TBL] [Abstract][Full Text] [Related]
35. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
[TBL] [Abstract][Full Text] [Related]
36. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
[TBL] [Abstract][Full Text] [Related]
37. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
38. The N6-methyladenosine methylation landscape stratifies breast cancer into two subtypes with distinct immunological characteristics.
Chen Y; Hou Y; Li S; Qin W; Zhang J
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13875. PubMed ID: 38797522
[TBL] [Abstract][Full Text] [Related]
39. N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma.
Wang J; Zuo Y; Lv C; Zhou M; Wan Y
IUBMB Life; 2023 Feb; 75(2):137-148. PubMed ID: 36177774
[TBL] [Abstract][Full Text] [Related]
40. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
